Convatec announced today that it plans to invest more than $1 billion over the next decade to accelerate its R&D efforts around the world. The global, multi-year planned investment includes $600 million going into the U.S. over the next 10 years. London-based Convatec said its planned investment marks a significant milestone in its mission, underlining […]
Convatec
Convatec wins FDA approval for Parkinson’s treatment infusion tech
Convatec announced today that it received FDA approval for the delivery of a Parkinson’s disease therapy through its Neria Guard infusion set. The FDA approved apomorphine hydrochloride for subcutaneous infusion for the treatment of Parkinson’s. London-based Convatec’s Neria Guard set delivers the therapy under the skin (subcutaneous) as a continuous infusion via a small portable […]
Convatec, Beta Bionics partner on iLet bionic pancreas
Convatec announced that it partnered with Beta Bionics on the launch of the iLet Bionic Pancreas for automated insulin delivery. FDA last week cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software. Convatec offers design and manufacturing services for infusion set technologies and insertion devices for insulin pump treatment. Beta […]
